Janeen Noel Doyle Janux Therapeutics, Inc. (JANX) insider trading activity

JANX Quotes by TradingView

Janeen Noel Doyle is Chief Corp. & Bus. Dev. Ofcr of Janux Therapeutics, Inc.. Currently has a direct ownership of 80,000 shares of JANX, which is worth approximately $2.34 Million. The most recent transaction as insider was on Jan 02, 2026, when has been sold 36,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 80K
81.82% 3M change
n/a 12M change
Total Value Held $2.34 Million

Janeen Noel Doyle Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 02 2026
BUY
Grant, award, or other acquisition
-
36,000 Added 31.03%
80,000 Common Stock
Jun 02 2025
BUY
Grant, award, or other acquisition
-
44,000 Added 50.0%
44,000 Common Stock
JND

Janeen Noel Doyle

Chief Corp. & Bus. Dev. Ofcr
San Diego, CA

Track Institutional and Insider Activities on JANX

Follow Janux Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JANX shares.

Notify only if

Insider Trading

Get notified when an Janux Therapeutics, Inc. insider buys or sells JANX shares.

Notify only if

News

Receive news related to Janux Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on JANX